Psychiatry & Neurology Doctors in Holmdel, NJ Accepting Medicare

8 Psychiatry & Neurology doctors found. Showing 1 - 8

Christine Carol Tintorer, M.D. Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 22 S Holmdel Rd Ste 5, Holmdel, NJ 07733 Phone: 732-444-1330    Fax: 732-444-1331

Mary-ann Abraham, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 5 Oakwood Ct, Holmdel, NJ 07733 Phone: 917-828-5347

Dr. Daniel Marc Weiner, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 727 N Beers St, Holmdel, NJ 07733 Phone: 732-776-4930

Dr. John Calvin Chatlos Jr., MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 973 Holmdel Rd, Holmdel, NJ 07733 Phone: 732-834-0368    Fax: 732-834-9891

Dr. Rafiya S Khakoo, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 721 N Beers St, Suite 2h, Holmdel, NJ 07733 Phone: 732-616-4751    Fax: 732-332-1339

Dr. Gurbachan Varma, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 721 N Beers St, Suite 1a, Holmdel, NJ 07733 Phone: 732-264-7803    Fax: 732-739-4408

Dr. Shefali Gandhi, D.O. Psychiatry & Neurology - Neurology Medicare: Medicare Enrolled Practice Location: 670 North Beers Street, Building 2, Suite 4, Holmdel, NJ 07733 Phone: 732-788-6537    Fax: 732-254-1558

Daniel A D'andrea, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 727 N Beers St, Holmdel, NJ 07733 Phone: 732-739-5665

News Archive

Inadequate mask and respirator use put health care workers at risk of 2009 H1N1 infection

Inadequate use of masks or respirators put health care workers at risk of 2009 H1N1 infection during the earliest stages of the 2009 pandemic in the U.S., according to a study published in the December issue of Infection Control and Hospital Epidemiology, the journal of the Society of Healthcare Epidemiology of America.

InTouch Health launches expanded suite of clinical workflow documentation and imaging solutions for telemedicine

InTouch Health® announced today the launch of an expanded suite of clinical workflow documentation and imaging solutions designed specifically for telemedicine. As cloud-based SaaS applications, SureNOTES™, SurePACS™, and StrokeRESPOND® are highly customizable to any clinical service, and provide a simple uniform toolset for the consulting physician while meeting the requirements of institutions' specific approved medical forms.

NeoGenomics, Definiens expand alliance to develop novel biomarker assays for clinical trials and testing

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, and Definiens, the leader in Tissue Phenomics solutions from biomarker discovery to meaningful diagnostics, today announced that they have expanded their alliance to develop and automate the analysis of new biomarker assays for clinical trials and routine clinical testing.

Bio-Path awarded $244,479 federal grant for Liposomal Grb-2 Phase I clinical trial

Bio-Path Holdings, Inc., a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that it has received a grant of $244,479 from the United States Government to help fund the Company's Phase I clinical trial of its lead cancer drug candidate Liposomal Grb-2. The amount of funds awarded was the maximum allocation allowed under the program.

Synageva BioPharma seeks FDA orphan drug designation for SBC-102 enzyme replacement therapy

Synageva BioPharma Corp., a privately held biopharmaceutical company, today announced its filing with the U.S. Food and Drug Administration (FDA) requesting orphan drug designation for its program, SBC-102. This program is an enzyme replacement therapy in preclinical development to treat lysosomal acid lipase (LAL) deficiency, also known as Wolman disease or cholesteryl ester storage disease (CESD), a condition for which there is currently no effective treatment.

Read more Medical News

› Verified 8 days ago